Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nick Roberts Insider Profile
4 Followers
Nick Roberts, Chief Financial Officer at Diaceutics, holds 63.21K shares in Diaceutics (Ticker: DIUXF). Most recently, Nick Roberts Bought $21,742 shares of Diaceutics on Jun 06, 2023 for an estimated value of 19.95K.
Nick Roberts Diaceutics (DIUXF)Chief Financial Officer
Diaceutics (DIUXF)
Chief Financial Officer
Ranked #54,694 out of 98,909 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-5.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Financial Officer
Roles that Nick Roberts holds in companies
Most Profitable Insider Trade
The most profitable trade made by Nick Roberts
Nick Roberts's Trading History
List of latest transactions for each holding click on a transaction to see Nick Roberts's performance on stock
You May Also Like
Nick Roberts insider profile FAQ
What is the percentage of profitable transactions made by Nick Roberts?
The percentage of profitable transactions made by Nick Roberts is 50%.
What is the average return per transaction made by Nick Roberts?
The average return per transaction made by Nick Roberts is -5.40%.
What stocks does Nick Roberts hold?
Nick Roberts holds: DIUXF stocks.
What was Nick Roberts’s latest transaction?
Nick Roberts latest transaction was an Informative Buy of $19.95K.
What was Nick Roberts's most profitable transaction?
Nick Roberts’s most profitable transaction was an Informative Buy of DIUXF stock on June 6, 2023. The return on the trade was 7.90%.
What is Nick Roberts's role in Diaceutics?
Nick Roberts's role in Diaceutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.